TY - JOUR
T1 - MELD-XI score predicts early mortality in patients after heart transplantation
AU - Grimm, Joshua C.
AU - Shah, Ashish S.
AU - Magruder, J. Trent
AU - Kilic, Arman
AU - Valero, Vicente
AU - Dungan, Samuel P.
AU - Tedford, Ryan J.
AU - Russell, Stuart D.
AU - Whitman, Glenn J.R.
AU - Sciortino, Christopher M.
N1 - Publisher Copyright:
© 2015 The Society of Thoracic Surgeons.
PY - 2015/11
Y1 - 2015/11
N2 - Background The aim of this study was to determine the utility of the Model for End-Stage Liver Disease Excluding INR (MELD-XI) in predicting early outcomes (30 days and 1 year) and late outcomes (5 years) in patients after orthotopic heart transplantation (OHT). Methods The United Network for Organ Sharing database was queried for all adult patients (aged ≥18 years) undergoing OHT from 2000 to 2012. A MELD-XI was calculated and the population stratified into score quartiles. Early and late survivals were compared among the MELD-XI cohorts. Multivariable Cox proportional hazards models were constructed to determine the capacity of MELD-XI (when modeled both as a categoric and a continuous variable) to predict 30-day, 1-year, and 5-year mortality. Conditional models were also designed to determine the effect of early mortality on long-term survival. Results A total of 22,597 patients were included for analysis. The MELD-XI cutoff scores were established as follows: low (10.5), low-intermediate (10.6 to 12.6), intermediate-high (12.7 to 16.4), and high (16.4). The high MELD-XI cohort experienced statistically worse 30-day, 1-year, and 5-year unconditional survivals when compared with patients with low scores (p 0.001). Similarly, a high MELD-XI score was also predictive of early and late mortality (0.001) after risk adjustment. There was, however, no difference in 5-year survival between the high score and low score cohorts after accounting for 1-year deaths. Subanalysis of patients bridged to transplant with a continuous-flow left ventricular assist device demonstrated similar findings. Conclusions This is the first known study to examine the relationship between a high MELD-XI score and outcomes in patients after OHT. Patients with hepatic or renal dysfunction before OHT should be closely monitored and aggressively optimized as early mortality appears to drive long-term outcomes.
AB - Background The aim of this study was to determine the utility of the Model for End-Stage Liver Disease Excluding INR (MELD-XI) in predicting early outcomes (30 days and 1 year) and late outcomes (5 years) in patients after orthotopic heart transplantation (OHT). Methods The United Network for Organ Sharing database was queried for all adult patients (aged ≥18 years) undergoing OHT from 2000 to 2012. A MELD-XI was calculated and the population stratified into score quartiles. Early and late survivals were compared among the MELD-XI cohorts. Multivariable Cox proportional hazards models were constructed to determine the capacity of MELD-XI (when modeled both as a categoric and a continuous variable) to predict 30-day, 1-year, and 5-year mortality. Conditional models were also designed to determine the effect of early mortality on long-term survival. Results A total of 22,597 patients were included for analysis. The MELD-XI cutoff scores were established as follows: low (10.5), low-intermediate (10.6 to 12.6), intermediate-high (12.7 to 16.4), and high (16.4). The high MELD-XI cohort experienced statistically worse 30-day, 1-year, and 5-year unconditional survivals when compared with patients with low scores (p 0.001). Similarly, a high MELD-XI score was also predictive of early and late mortality (0.001) after risk adjustment. There was, however, no difference in 5-year survival between the high score and low score cohorts after accounting for 1-year deaths. Subanalysis of patients bridged to transplant with a continuous-flow left ventricular assist device demonstrated similar findings. Conclusions This is the first known study to examine the relationship between a high MELD-XI score and outcomes in patients after OHT. Patients with hepatic or renal dysfunction before OHT should be closely monitored and aggressively optimized as early mortality appears to drive long-term outcomes.
UR - http://www.scopus.com/inward/record.url?scp=84946480584&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946480584&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2015.07.026
DO - 10.1016/j.athoracsur.2015.07.026
M3 - Article
C2 - 26387720
AN - SCOPUS:84946480584
VL - 100
SP - 1737
EP - 1743
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
SN - 0003-4975
IS - 5
ER -